74 filings
15-12G
Coeptis Therapeutics Inc.
14 Dec 22
Securities registration termination
12:10pm
10-Q
2022 Q3
Coeptis Therapeutics Inc.
Quarterly report
8 Nov 22
2:54pm
4
Chris Calise
1 Nov 22
Coeptis Therapeutics / Robert Striar ownership change
7:30pm
8-K
Coeptis Therapeutics Inc.
28 Oct 22
Submission of Matters to a Vote of Security Holders
9:13am
DEFM14A
Coeptis Therapeutics Inc.
30 Sep 22
Proxy related to merger
2:27pm
8-K
Coeptis Therapeutics Inc.
21 Sep 22
Regulation FD Disclosure
12:17pm
DEFA14A
Coeptis Therapeutics Inc.
21 Sep 22
Additional proxy soliciting materials
12:15pm
SC 13G
Coeptis Therapeutics Inc.
19 Sep 22
Coeptis Therapeutics / Hutchinson Thomas ownership change
5:21pm
PREM14A
Coeptis Therapeutics Inc.
16 Sep 22
Preliminary proxy related to merger
5:08pm
253G2
Coeptis Therapeutics Inc.
7 Sep 22
Offering circular supplement
5:07pm
8-K
Coeptis Therapeutics Inc.
7 Sep 22
Entry into a Material Definitive Agreement
4:50pm
DEFA14A
Coeptis Therapeutics Inc.
7 Sep 22
Additional proxy soliciting materials
4:48pm
8-K
Coeptis Therapeutics Inc.
22 Aug 22
Termination of a Material Definitive Agreement
5:24pm
DEFA14A
Coeptis Therapeutics Inc.
22 Aug 22
Additional proxy soliciting materials
5:22pm
UPLOAD
Coeptis Therapeutics Inc.
15 Aug 22
Letter from SEC
12:00am
CORRESP
Coeptis Therapeutics Inc.
8 Aug 22
Correspondence with SEC
12:00am
UPLOAD
Coeptis Therapeutics Inc.
4 Aug 22
Letter from SEC
12:00am
CORRESP
Coeptis Therapeutics Inc.
3 Aug 22
Correspondence with SEC
12:00am
10-Q
2022 Q2
Coeptis Therapeutics Inc.
Quarterly report
2 Aug 22
3:07pm
UPLOAD
Coeptis Therapeutics Inc.
20 Jul 22
Letter from SEC
12:00am